Ruhi Deshmukh

Ruhi Deshmukh

Auto-generated profile, based on publicly available information

Ruhi Deshmukh

Cancer Research UK Scotland Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
RKRajni Kumari
Rajni Kumari
RDRuhi S. Deshmukh
Ruhi S. Deshmukh
SDSanjeev Das
Sanjeev Das
Caspase-10 belongs to the class of initiator caspases and is a close homolog of caspase-8. However, the lack of caspase-10 in mice and limited substrate repertoire restricts the understanding of its physiological functions. Here, we report that ATP-citrate lyase (ACLY) is a caspase-10 substrate. Caspase-10 cleaves ACLY at the conserved Asp1026 site under conditions of altered metabolic homeostasis. Cleavage of ACLY abrogates its enzymatic activity and suppresses the generation of acetyl-CoA, which is critical for lipogenesis and histone acetylation. Thus, caspase-10-mediated ACLY cleavage results in reduced intracellular lipid levels and represses GCN5-mediated histone H3 and H4 acetylation. Furthermore, decline in GCN5 activity alters the epigenetic profile, resulting in downregulation of proliferative and metastatic genes. Thus caspase-10 suppresses ACLY-promoted malignant phenotype. These findings expand the substrate repertoire of caspase-10 and highlight its pivotal role in inhibiting tumorigenesis through metabolic and epigenetic mechanisms.

1 November 2021 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
RDRuhi Deshmukh
Ruhi Deshmukh
MAMaria Francesca Allega
Maria Francesca Allega
STSaverio Tardito
Saverio Tardito

24 October 2022 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
Victor H. VillarVictor H. Villar
Victor H. Villar
MAMaria Francesca Allega
Maria Francesca Allega
RDRuhi Deshmukh
Ruhi Deshmukh
TATobias Ackermann
Tobias Ackermann
MNMark A. Nakasone
Mark A. Nakasone
STSaverio Tardito
Saverio Tardito
Glutamine synthetase (GS) activity is conserved from prokaryotes to humans, where the ATP-dependent production of glutamine from glutamate and ammonia is essential for neurotransmission and ammonia detoxification. Here, we show that mammalian GS uses glutamate and methylamine to produce a methylated glutamine analog,N5-methylglutamine. Untargeted metabolomics revealed that liver-specific GS deletion and its pharmacological inhibition in mice suppress hepatic and circulating levels ofN5-methylglutamine. This alternative activity of GS was confirmed in human recombinant enzyme and cells, where a pathogenic mutation in the active site (R324C) promoted the synthesis ofN5-methylglutamine over glutamine.N5-methylglutamine is detected in the circulation, and its levels are sustained by the microbiome, as demonstrated by using germ-free mice. Finally, we show that urine levels ofN5-methylglutamine correlate with tumor burden and GS expression in a β-catenin-driven model of liver cancer, highlighting the translational potential of this uncharacterized metabolite.

15 November 2018 in Cancer Research
Verified
Journal Article
Closed access
PDF file
RDRuhi S. Deshmukh
Ruhi S. Deshmukh
SSShalakha Sharma
Shalakha Sharma
SDSanjeev Das
Sanjeev Das
Cyclin F is a substrate recognition subunit of Skp1-Cul1-F-box protein (SCF) E3 ubiquitin ligase complex. Although there have been reports describing the role of cyclin F in the genotoxic stress response, its function under conditions of altered metabolic homeostasis remain unexplored. Here we report that cyclin F is induced upon metabolic stress in a FOXO1-dependent manner. Under metabolic stress conditions, cyclin F mediated polyubiquitylation of RBPJ at Lys315, leading to its proteasomal degradation. RBPJ regulated the expression of IDH1, which is often mutated to an oncogenic form IDH1R132H in cancers. Thus, metabolic stress–induced cyclin F attenuated the oncogenic functions of IDH1R132H in an RBPJ-dependent manner. Studies in mouse tumor models indicated that abrogation of cyclin F expression facilitates IDH1R132H-mediated tumorigenesis and metastasis. In addition, increased IDH1R132H levels correlated with reduced cyclin F levels in increasing grades of glioma. These findings highlight a novel aspect of cyclin F functions in inhibiting tumorigenesis and provide mechanistic insights into regulation of IDH1R132H. Significance: These findings reveal mechanistic insights into the key role of the cyclin F-RBPJ axis in response to metabolic stress in cancer cells. Cancer Res; 78(22); 6386–98. ©2018 AACR.

21 October 2024 in EMBO Molecular Medicine
Verified
Journal Article
Open access
TATobias Ackermann
Tobias Ackermann
ESEngy Shokry
Engy Shokry
RDRuhi Deshmukh
Ruhi Deshmukh
JAJayanthi Anand
Jayanthi Anand
LGLaura C A Galbraith
Laura C A Galbraith
STSaverio Tardito
Saverio Tardito
The limited availability of therapeutic options for patients with triple-negative breast cancer (TNBC) contributes to the high rate of metastatic recurrence and poor prognosis. Ferroptosis is a type of cell death caused by iron-dependent lipid peroxidation and counteracted by the antioxidant activity of the selenoprotein GPX4. Here, we show that TNBC cells secrete an anti-ferroptotic factor in the extracellular environment when cultured at high cell densities but are primed to ferroptosis when forming colonies at low density. We found that secretion of the anti-ferroptotic factors, identified as monounsaturated fatty acid (MUFA) containing lipids, and the vulnerability to ferroptosis of single cells depends on the low expression of stearyl-CoA desaturase (SCD) that is proportional to cell density. Finally, we show that the inhibition of Sec-tRNAsec biosynthesis, an essential step for selenoprotein production, causes ferroptosis and impairs the lung seeding of circulating TNBC cells that are no longer protected by the MUFA-rich environment of the primary tumour.

14 March 2012 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
RDRuhi S. Deshmukh
Ruhi S. Deshmukh
RCRajeev K. Chaudhary
Rajeev K. Chaudhary
IRIpsita Roy
Ipsita Roy